FormWeb • efavirenz-emtricitabine-tenofovir disoproxil fumarate

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

efavirenz-emtricitabine-tenofovir disoproxil fumarate

efavirenz-emtricitabine-tenofovir disoproxil fumarate

Formulary AIDS Drugs Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Atripla	TABLET, ORAL	600 mg-200 mg-300 mg

Comments:

No longer routinely stocked (February 2026). May use home supply.

Individual agents may be dispensed separately if home supply unavailable.

Reviewed: September 26, 2006

Last updated: Feb. 19, 2026

Black Box Warning: Lactic Acidosis; Severe Hepatomegaly with Steatosis and Post Treatment Exacerbation of Hepatitis B
Formulary, Not Routinely Stocked: Atripla

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.